Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy.

[1]  T. Mala,et al.  Clinical prediction of survival by surgeons for patients with incurable abdominal malignancy. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  M. Shlipak,et al.  Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. , 2011, JAMA.

[3]  J. Tanne.  Americans are living longer, but obesity and diabetes are rising , 2011, BMJ : British Medical Journal.

[4]  Susan C. Miller,et al.  Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. , 2010, JAMA.

[5]  M. Kattan,et al.  Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. , 2010, European urology.

[6]  C. Yen,et al.  Life expectancy, expected years of life lost and survival of hemodialysis and peritoneal dialysis patients. , 2010, Journal of nephrology.

[7]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[8]  P. Ewings,et al.  How accurate are doctors, nurses and medical students at predicting life expectancy? , 2009, European journal of internal medicine.

[9]  Andrew J Vickers,et al.  Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Michael G Downing,et al.  Using the Palliative Performance Scale to provide meaningful survival estimates. , 2009, Journal of pain and symptom management.

[11]  M. Cooperberg,et al.  Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. , 2009, Journal of the National Cancer Institute.

[12]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[13]  M. Katz.  A Nomogram Predicting 10-Year Life Expectancy in Candidates for Radical Prostatectomy or Radiotherapy for Prostate Cancer , 2008 .

[14]  A. Rigby,et al.  Mortality at Low and High Estimated Glomerular Filtration Rate Values: A ‘U’ Shaped Curve , 2008, Nephron Clinical Practice.

[15]  T. Hostetter,et al.  Automatic reporting of estimated glomerular filtration rate--just what the doctor ordered. , 2006, Clinical chemistry.

[16]  M. Brundage,et al.  Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent , 2006, Cancer.

[17]  P. Chaves,et al.  Kidney function as a predictor of noncardiovascular mortality. , 2005, Journal of the American Society of Nephrology : JASN.

[18]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[19]  D. Siscovick,et al.  Cystatin C and the risk of death and cardiovascular events among elderly persons. , 2005, The New England journal of medicine.

[20]  E. Paci,et al.  Predicting survival in terminal cancer patients: clinical observation or quality-of-life evaluation? , 2005, Palliative medicine.

[21]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[22]  Deeb N Salem,et al.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.

[23]  M. Menon,et al.  Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. , 2004, The Journal of urology.

[24]  A. D'Amico,et al.  Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Jiang He,et al.  Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.

[26]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[27]  N. Christakis,et al.  Survival of Medicare patients after enrollment in hospice programs. , 1996, The New England journal of medicine.

[28]  D. Fryback,et al.  The impact of co-morbidity on life expectancy among men with localized prostate cancer. , 1996, The Journal of urology.

[29]  R. Elashoff,et al.  Flaws in mortality data. The hazards of ignoring comorbid disease. , 1988, JAMA.

[30]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[31]  M. Cowen,et al.  Predicting life expectancy in men with clinically localized prostate cancer. , 2006, The Journal of urology.